CME
CME Group Inc
263.10$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.3% | +1.8% | -6.6% | +11.7% | -0.3% | +14.8% | +14.0% | +4.0% | +6.1% | +1.7% | -3.6% | |
| – | +4.5% | +2.5% | -8.8% | +16.2% | -0.1% | +19.8% | +17.8% | +5.1% | -96.6% | +3,157.8% | -4.4% | |
| – | +26.6% | -50.7% | +24.6% | +29.7% | +24.6% | -51.4% | +41.0% | +23.5% | +80.8% | -45.9% | -10.3% | |
| – | +25.8% | -48.5% | +22.7% | +27.3% | +23.5% | -49.5% | +38.2% | +22.4% | +77.0% | -44.7% | -9.5% | |
| – | -4.1% | +17.3% | -4.6% | +5.0% | -8.9% | +34.4% | -13.3% | -3.7% | -0.6% | +46.4% | -19.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | -0.1% | 0.0% | +0.2% | -0.3% | +0.1% | +0.2% | -0.1% | +0.0% | -0.1% | 0.0% | |
| – | -0.2% | -0.3% | -0.3% | -0.2% | -0.4% | -0.2% | -0.2% | -13.7% | +15.2% | -13.2% | +0.0% | |
| – | +5.7% | +1.9% | -8.7% | +14.5% | +1.3% | +17.9% | +16.3% | +4.5% | +6.8% | +3.3% | -4.1% | |
| – | +6.3% | +2.9% | -9.5% | +15.9% | +1.5% | +18.7% | +17.6% | +4.8% | +7.2% | +3.6% | -4.3% | |
| – | -0.2% | +1,259.9% | +0.0% | +0.0% | +0.0% | – | – | +3.4% | +1.1% | – | – | |
| – | +68.4% | +22.5% | -10.0% | +30.0% | -38.5% | +25.4% | -7.9% | -18.9% | -4.1% | +5.0% | -9.8% | |
| – | +0.0% | -21.9% | +0.0% | +0.0% | +0.0% | +27.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -5.0% | +1.6% | +1.8% | +2.1% | -6.1% | +2.1% | +2.6% | +1.6% | +1.9% | -7.3% | -0.4% | |
| – | -25.2% | +9.8% | +9.5% | +9.2% | -28.4% | +11.9% | +12.1% | +8.6% | +12.7% | -24.1% | +11.7% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.8% | -0.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.